Helius Medical Technologies, Inc., a neurotechnology company, focuses on developing, licensing, and acquiring non-invasive technologies for the treatment of symptoms caused by neurological disease or trauma. Its product, Portable Neuromodulation Stimulator (PoNS), is a non-surgical medical device intended for use as a short term treatment of gait deficit due to symptoms from multiple sclerosis and balance deficit due to mild-to-moderate traumatic brain injury, as well as to be used in conjunction with supervised therapeutic exercise. The company is headquartered in Newtown, Pennsylvania.


2024-11-12	51 K	100 K
2024-08-12	182 K	150 K
2024-05-13	135 K	130 K
2024-03-28	134 K	250 K
2023-11-09	143 K	280 K
2023-08-10	256 K	320 K
2023-05-11	111 K	400 K
2023-03-09	282 K	260 K
2022-11-14	196 K	0
2022-08-15	119 K	0
2022-05-12	190 K	186.64 K
2022-03-14	258 K	160 K
2021-11-10	109 K	92.81 K
2021-08-12	71 K	55.13 K
2021-05-17	84 K	0
2021-03-10	191 K	0
2020-11-12	131 K	0
2020-08-12	133 K	0
2020-05-07	207 K	0
2020-03-12	152 K	0
2019-11-12	150 K	150 K
2019-08-08	518 K	11.4 M
2019-05-09	677 K	3.38 M
2019-03-14	478 K	455.24 K

Helius Medical Technologies, Inc.

HSDT | NASDAQ Capital Market